171 related articles for article (PubMed ID: 9508526)
1. Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis.
Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Leeuwen DJ; Tytgat GN
Dig Dis Sci; 1998 Jan; 43(1):203-13. PubMed ID: 9508526
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy.
Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Gulik TM; de Wit LT; Gouma DJ; van Leeuwen DJ; Tytgat GN
Br J Surg; 1997 Jul; 84(7):952-6. PubMed ID: 9240133
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous assessments of exocrine pancreatic function by cholesteryl-[14C]octanoate breath test and measurement of plasma p-aminobenzoic acid.
Bruno MJ; Hoek FJ; Delzenne B; van Leeuwen DJ; Schteingart CD; Hofmann AF; Tytgat GN
Clin Chem; 1995 Apr; 41(4):599-604. PubMed ID: 7720253
[TBL] [Abstract][Full Text] [Related]
4. Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test.
Mundlos S; Kühnelt P; Adler G
Gut; 1990 Nov; 31(11):1324-8. PubMed ID: 2253920
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency.
Halm U; Löser C; Löhr M; Katschinski M; Mössner J
Aliment Pharmacol Ther; 1999 Jul; 13(7):951-7. PubMed ID: 10383531
[TBL] [Abstract][Full Text] [Related]
6. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis.
O'Keefe SJ; Cariem AK; Levy M
J Clin Gastroenterol; 2001 Apr; 32(4):319-23. PubMed ID: 11276275
[TBL] [Abstract][Full Text] [Related]
7. Gastric emptying of pancreatin granules and dietary lipids in pancreatic insufficiency.
Nørregaard P; Lysgaard Madsen J; Larsen S; Worning H
Aliment Pharmacol Ther; 1996 Jun; 10(3):427-32. PubMed ID: 8791973
[TBL] [Abstract][Full Text] [Related]
8. Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis.
Taylor CJ; Hillel PG; Ghosal S; Frier M; Senior S; Tindale WB; Read N
Arch Dis Child; 1999 Feb; 80(2):149-52. PubMed ID: 10325730
[TBL] [Abstract][Full Text] [Related]
9. In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values.
Gan KH; Geus WP; Bakker W; Lamers CB; Heijerman HG
Aliment Pharmacol Ther; 1996 Oct; 10(5):771-5. PubMed ID: 8899086
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
[TBL] [Abstract][Full Text] [Related]
11. [Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity].
Kühnelt P; Mundlos S; Adler G
Z Gastroenterol; 1991 Sep; 29(9):417-21. PubMed ID: 1763562
[TBL] [Abstract][Full Text] [Related]
12. The cholesteryl octanoate breath test: a new procedure for detection of pancreatic insufficiency in the rat.
Mundlos S; Rhodes JB; Hofmann AF
Pediatr Res; 1987 Sep; 22(3):257-61. PubMed ID: 3116494
[TBL] [Abstract][Full Text] [Related]
13. Optimal size range for enteric-coated pancreatin preparations.
Lederer PC
Pancreas; 2011 Mar; 40(2):310-1. PubMed ID: 21311309
[No Abstract] [Full Text] [Related]
14. The use of dual-isotope imaging to compare the gastrointestinal transit of food and pancreatic enzyme pellets in cystic fibrosis patients.
Hillel PG; Tindale WB; Taylor CJ; Frier M; Senior S; Ghosal S
Nucl Med Commun; 1998 Aug; 19(8):761-9. PubMed ID: 9751930
[TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.
Thorat V; Reddy N; Bhatia S; Bapaye A; Rajkumar JS; Kini DD; Kalla MM; Ramesh H
Aliment Pharmacol Ther; 2012 Sep; 36(5):426-36. PubMed ID: 22762290
[TBL] [Abstract][Full Text] [Related]
16. Cholesteryl octanoate breath test. Preliminary studies on a new noninvasive test of human pancreatic exocrine function.
Cole SG; Rossi S; Stern A; Hofmann AF
Gastroenterology; 1987 Dec; 93(6):1372-80. PubMed ID: 3678753
[TBL] [Abstract][Full Text] [Related]
17. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
19. Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres.
Meyer JH; Lake R
Pancreas; 1997 Oct; 15(3):226-35. PubMed ID: 9336785
[TBL] [Abstract][Full Text] [Related]
20. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.
Stead RJ; Skypala I; Hodson ME; Batten JC
Thorax; 1987 Jul; 42(7):533-7. PubMed ID: 3326213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
